MDM2 and cancer: The patients with high‐mRNA expression levels of either USP7 (Fig. 7A) or MDM2 (Fig. 7B) had a short survival period and obvious cancer‐promoting characteristics, while patients with high expression levels of DICER (Fig. 7C) had longer survival and cancer suppression characteristics.